Squarepoint’s Sangrix SGRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
– Sell
-8
Closed -$19.5K – 4626
2024
Q4
$19.5K Buy
+8
New +$30.8K ﹤0.01% 4937
2021
Q2
– Sell
-2
Closed -$148K – 3249
2021
Q1
$148K Buy
+2
New +$156K ﹤0.01% 2791
2020
Q1
– Sell
-1
Closed -$268K – 1912
2019
Q4
$268K Buy
+1
New +$304K ﹤0.01% 2095
2019
Q3
– Hold
0
– – – 2198

Other funds holding SGRX

Squarepoint's SGRX Position: Q1 2025 in Review

Squarepoint sold out of Sangrix (SGRX) in Q1 2025, closing a stake of 8 shares — an estimated $19.5K sold.

Squarepoint first reported a position in SGRX in Q4 2019 and held it in 3 quarters. The position peaked at $268K in Q4 2019. 3 funds tracked by Wall St. Rank hold SGRX as of Q1 2025.

  • Squarepoint reported no remaining Sangrix position as of Q1 2025 after selling out during the quarter.
  • Squarepoint sold 8 Sangrix shares in Q1 2025, an estimated $19.5K.
  • Squarepoint first reported a position in Sangrix in Q4 2019 and held it in 3 quarters.
  • Squarepoint's Sangrix position peaked at $268K in Q4 2019.
  • 3 funds tracked by Wall St. Rank held Sangrix as of Q1 2025.

Based on Squarepoint's 13F filing for Q1 2025, filed 15 May 2025.